Delivery Order SPE2DB25D3003-SPE2DB25FPXFQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,843.65 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pens on September 16, 2025, with completion scheduled for September 17, 2025. This delivery order represents a firm fixed price procurement issued under a non-set-aside competitive acquisition. The award was placed to AmerisourceBergen Drug Corp's corporate office located in Conshohocken, Pennsylvania, reflecting the company's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $19,487.23 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a single delivery transaction under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens valued at $5,094.18. This is a firm fixed-price delivery order with an ultimate completion date of September 5, 2025, issued on September 4, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $40,073.85 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on June 16, 2025, with completion scheduled for June 17, 2025. This is a firm fixed price, non-set-aside delivery order for pharmaceutical products to be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a $6,311.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens with a completion date of September 15, 2025. The award was not designated as a set-aside contract and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $13,775.88 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pens on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and represents a single-line pharmaceutical procurement supporting federal medical supply requirements. The order is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $9,379.27 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order is issued without set-aside status, indicating competitive award based on open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen medication on July 25, 2025, with completion targeted for July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $1,907.36 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation, and performance is scheduled to conclude on July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPXFQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $14,291.18 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 23, 2025, with a completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026 that enables the contractor to supply medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated significant capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a broad range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order represents a routine transaction within the contractor's larger framework agreement, continuing AmerisourceBergen's role as a critical vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 9/23/25 |